FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3193516441> ?p ?o ?g. }

• W3193516441 endingPage "279" @default.
• W3193516441 startingPage "279" @default.
• W3193516441 abstract "Recognised cardiac complications of coronavirus disease 2019 (COVID-19) include arrhythmias,1, 2 myopericarditis,3 and cardiomyopathy,4, 5 but data on their incidence are limited. The Australian Cardiovascular COVID-19 Registry (AUS-COVID), an observational cohort study in 21 hospitals, is assessing the incidence of cardiac complications of COVID-19. The registry includes data on all index hospitalisations of people with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections (protocol and case report form: https://www.aus-covid.com). The registry was approved by the Northern Sydney Local Health District Human Research Ethics Committee (HREC2020/ETH00732), which granted a waiver of individual patient consent, and was prospectively registered with the Australian and New Zealand Clinical Trials Registry on 17 April 2020 (ACTRN12620000486921). We analysed data for 644 consecutive patients included in the AUS-COVID Registry by 28 January 2021 (mean age, 62.5 years; standard deviation, 20.1 years), including 329 men (51%). One hundred and twenty-five patients (19%) were admitted to intensive care units, and 70 patients (11%) required intubation; 92 patients (14%) died in hospital. Outcomes for 15 patients (2%) transferred to other hospitals were not known. Twenty of 553 patients without histories of atrial fibrillation or flutter were diagnosed with the condition (4%). Of 588 patients who did not have permanent pacemakers or implantable cardioverter defibrillators, three (0.5%) developed high grade atrioventricular (AV) block (one, Mobitz II AV block; two, third degree AV block). No patients developed torsades de pointes. Nine of the 572 patients without prior diagnoses of heart failure or cardiomyopathy (2%) were diagnosed with new heart failure or cardiomyopathy. Of the six who underwent echocardiography, four had left ventricular ejection fractions of less than 50%, one was reported as having mild left ventricular impairment but no ejection fraction was recorded, and one had elevated levels of B-type natriuretic peptide (BNP). Corresponding data were not available for the other three patients, who had clinical diagnoses of heart failure. Two patients had clinical diagnoses of pericarditis; the troponin level was mildly elevated in one (less than five times the upper limit of normal), suggesting possible myopericarditis. Neither patient underwent echocardiography, cardiac magnetic resonance imaging, or biopsy. Limitations of our study include the facts that it did not capture subclinical complications, as investigations were undertaken only if clinically indicated, and that there was no comparator group, so we could not compare the incidence of cardiac complications with those of other viral illnesses. Further, we had no information on patient outcomes after their discharge from hospital; cardiac complications such as heart failure and myopericarditis may become apparent only weeks after discharge. Nevertheless, the AUS-COVID Registry provides important insights into the incidence of clinically apparent cardiac complications in patients hospitalised with COVID-19. While clinicians should remain vigilant, the incidence of clinical cardiac complications during index hospitalisations was reassuringly low in our multicentre study of more than 600 consecutive patients admitted to Australian hospitals with COVID-19. The study was funded by the Paul Ramsay Foundation and the Northern Sydney Local Health District. No relevant disclosures." @default.
• W3193516441 created "2021-08-30" @default.
• W3193516441 creator A5000514223 @default.
• W3193516441 creator A5001504324 @default.
• W3193516441 creator A5001965394 @default.
• W3193516441 creator A5008523536 @default.
• W3193516441 creator A5010284968 @default.
• W3193516441 creator A5012111658 @default.
• W3193516441 creator A5016042133 @default.
• W3193516441 creator A5016168787 @default.
• W3193516441 creator A5020832846 @default.
• W3193516441 creator A5021232751 @default.
• W3193516441 creator A5021578578 @default.
• W3193516441 creator A5023377002 @default.
• W3193516441 creator A5024547758 @default.
• W3193516441 creator A5028229549 @default.
• W3193516441 creator A5033633551 @default.
• W3193516441 creator A5037136480 @default.
• W3193516441 creator A5039528724 @default.
• W3193516441 creator A5043591352 @default.
• W3193516441 creator A5044964182 @default.
• W3193516441 creator A5045230091 @default.
• W3193516441 creator A5045302681 @default.
• W3193516441 creator A5049116973 @default.
• W3193516441 creator A5050136369 @default.
• W3193516441 creator A5052626142 @default.
• W3193516441 creator A5058253091 @default.
• W3193516441 creator A5060282911 @default.
• W3193516441 creator A5063447489 @default.
• W3193516441 creator A5065203122 @default.
• W3193516441 creator A5071719776 @default.
• W3193516441 creator A5073671635 @default.
• W3193516441 creator A5074394224 @default.
• W3193516441 creator A5081766221 @default.
• W3193516441 creator A5084419225 @default.
• W3193516441 creator A5087379432 @default.
• W3193516441 creator A5088693931 @default.
• W3193516441 creator A5091841174 @default.
• W3193516441 date "2021-08-17" @default.
• W3193516441 modified "2023-10-16" @default.
• W3193516441 title "The incidence of cardiac complications in patients hospitalised with COVID‐19 in Australia: the AUS‐COVID study" @default.
• W3193516441 cites W3011559677 @default.
• W3193516441 cites W3030700284 @default.
• W3193516441 cites W3049282888 @default.
• W3193516441 cites W3056789882 @default.
• W3193516441 cites W3089519570 @default.
• W3193516441 doi "https://doi.org/10.5694/mja2.51225" @default.
• W3193516441 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8446954" @default.
• W3193516441 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34405420" @default.
• W3193516441 hasPublicationYear "2021" @default.
• W3193516441 type Work @default.
• W3193516441 sameAs 3193516441 @default.
• W3193516441 citedByCount "3" @default.
• W3193516441 countsByYear W31935164412022 @default.
• W3193516441 crossrefType "journal-article" @default.
• W3193516441 hasAuthorship W3193516441A5000514223 @default.
• W3193516441 hasAuthorship W3193516441A5001504324 @default.
• W3193516441 hasAuthorship W3193516441A5001965394 @default.
• W3193516441 hasAuthorship W3193516441A5008523536 @default.
• W3193516441 hasAuthorship W3193516441A5010284968 @default.
• W3193516441 hasAuthorship W3193516441A5012111658 @default.
• W3193516441 hasAuthorship W3193516441A5016042133 @default.
• W3193516441 hasAuthorship W3193516441A5016168787 @default.
• W3193516441 hasAuthorship W3193516441A5020832846 @default.
• W3193516441 hasAuthorship W3193516441A5021232751 @default.
• W3193516441 hasAuthorship W3193516441A5021578578 @default.
• W3193516441 hasAuthorship W3193516441A5023377002 @default.
• W3193516441 hasAuthorship W3193516441A5024547758 @default.
• W3193516441 hasAuthorship W3193516441A5028229549 @default.
• W3193516441 hasAuthorship W3193516441A5033633551 @default.
• W3193516441 hasAuthorship W3193516441A5037136480 @default.
• W3193516441 hasAuthorship W3193516441A5039528724 @default.
• W3193516441 hasAuthorship W3193516441A5043591352 @default.
• W3193516441 hasAuthorship W3193516441A5044964182 @default.
• W3193516441 hasAuthorship W3193516441A5045230091 @default.
• W3193516441 hasAuthorship W3193516441A5045302681 @default.
• W3193516441 hasAuthorship W3193516441A5049116973 @default.
• W3193516441 hasAuthorship W3193516441A5050136369 @default.
• W3193516441 hasAuthorship W3193516441A5052626142 @default.
• W3193516441 hasAuthorship W3193516441A5058253091 @default.
• W3193516441 hasAuthorship W3193516441A5060282911 @default.
• W3193516441 hasAuthorship W3193516441A5063447489 @default.
• W3193516441 hasAuthorship W3193516441A5065203122 @default.
• W3193516441 hasAuthorship W3193516441A5071719776 @default.
• W3193516441 hasAuthorship W3193516441A5073671635 @default.
• W3193516441 hasAuthorship W3193516441A5074394224 @default.
• W3193516441 hasAuthorship W3193516441A5081766221 @default.
• W3193516441 hasAuthorship W3193516441A5084419225 @default.
• W3193516441 hasAuthorship W3193516441A5087379432 @default.
• W3193516441 hasAuthorship W3193516441A5088693931 @default.
• W3193516441 hasAuthorship W3193516441A5091841174 @default.
• W3193516441 hasBestOaLocation W31935164411 @default.
• W3193516441 hasConcept C107130276 @default.
• W3193516441 hasConcept C120665830 @default.
• W3193516441 hasConcept C121332964 @default.
• W3193516441 hasConcept C126322002 @default.
• W3193516441 hasConcept C187212893 @default.
• W3193516441 hasConcept C194828623 @default.

• next